Evaluation of Potential Urologic Prescription Drug Savings With Mark Cuban Cost Plus Drug Company
- Van Schloegel
- , Loyall Harris
- , Andrew Harris
- , Benjamin Dropkin
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations